Intervention not reported
Treatment failureday‐28 PCR‐adjusted(ITT population) · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in treatment failureday‐28 PCR‐adjusted(ITT population) (low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in serious adverse events (low certainty).
1 finding from 1 review
Intervention not reported
Drug‐related adverse events · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention probably leads to lower drug‐related adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Drug‐related vomiting · children aged 14 years or younger with uncomplicated P falciparum malaria
The intervention showed no clear difference in drug‐related vomiting (low certainty).
1 finding from 1 review
Intervention not reported
Acceptability · children aged 14 years or younger with uncomplicated P falciparum malaria
1 finding from 1 review
Intervention not reported
Weight gain (g/kg/d) · preterm infants
1 finding from 1 review
Intervention not reported
Length gain (mm/week) · preterm infants
1 finding from 1 review
Intervention not reported
Head circumference gain (mm/week) · preterm infants
1 finding from 1 review
Intervention not reported
Mental Development Index (MDI) at 18 months · preterm infants
1 finding from 1 review
Intervention not reported
Psychomotor Development Index (PDI) at 18 months · preterm infants
1 finding from 1 review
Intervention not reported
Necrotising enterocolitis · preterm infants
The intervention showed no clear difference in necrotising enterocolitis (low certainty).
1 finding from 1 review
Intervention not reported
Treatment failure · treating pulmonary TB
The intervention showed no clear difference in treatment failure (moderate certainty).
1 finding from 1 review
Intervention not reported
Relapse · treating pulmonary TB
The intervention showed no clear difference in relapse (low certainty).
1 finding from 1 review
Intervention not reported
Death · treating pulmonary TB
The intervention showed no clear difference in death (moderate certainty).
1 finding from 1 review
Intervention not reported
Sputum smear or culture conversion at end of treatment · treating pulmonary TB
The intervention showed no clear difference in sputum smear or culture conversion at end of treatment (high certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events · treating pulmonary TB
The intervention showed no clear difference in serious adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events leading to discontinuation of therapy · treating pulmonary TB
The intervention showed no clear difference in adverse events leading to discontinuation of therapy (low certainty).
1 finding from 1 review
Intervention not reported
Combined endpoint of treatment failure, relapse, or death** · treating pulmonary TB
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
Immunonutrition may leads to lower all‐cause mortality compared with control (low certainty).
1 finding from 1 review
All‐cause mortality · patients with acute pancreatitis
1 finding from 1 review